Literature DB >> 23362923

Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.

Alexander Bochen1, Udaya Kiran Marelli, Elke Otto, Diego Pallarola, Carlos Mas-Moruno, Francesco Saverio Di Leva, Heike Boehm, Joachim P Spatz, Ettore Novellino, Horst Kessler, Luciana Marinelli.   

Abstract

Integrins are the major class of cell adhesion proteins. Their interaction with different ligands of the extracellular matrix is diverse. To get more insight into these interactions, artificial ligands endowed with a well-defined activity/selectivity profile are necessary. Herein, we present a library of cyclic pentapeptides, based on our previously reported peptide motif c(-phg-isoDGR-X-), in which high activity toward fibronectin binding integrins α5β1 and αvβ6 and not on vitronectin binding integrins αvβ3 and αvβ5 has been achieved by changing the flanking amino acids. The structure of the most promising candidates has been determined using a combined approach of NMR, distance geometry, and molecular dynamics simulations, and docking studies have been further used to elucidate the peptide-integrin interactions at the molecular level. The peptides' binding affinity has been characterized by enzyme linked immunosorbent assay experiments, and the results have been verified by cell adhesion experiments on specifically functionalized surfaces.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23362923     DOI: 10.1021/jm301221x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.

Authors:  James Adams; Edward C Anderson; Emma E Blackham; Yin Wa Ryan Chiu; Thomas Clarke; Natasha Eccles; Luke A Gill; Joshua J Haye; Harvey T Haywood; Christian R Hoenig; Marius Kausas; Joelle Le; Hannah L Russell; Christopher Smedley; William J Tipping; Tom Tongue; Charlotte C Wood; Jason Yeung; James E Rowedder; M Jonathan Fray; Thomas McInally; Simon J F Macdonald
Journal:  ACS Med Chem Lett       Date:  2014-09-19       Impact factor: 4.345

2.  Local remodeling of synthetic extracellular matrix microenvironments by co-cultured endometrial epithelial and stromal cells enables long-term dynamic physiological function.

Authors:  Christi D Cook; Abby S Hill; Margaret Guo; Linda Stockdale; Julia P Papps; Keith B Isaacson; Douglas A Lauffenburger; Linda G Griffith
Journal:  Integr Biol (Camb)       Date:  2017-04-18       Impact factor: 2.192

3.  Dissociation Constant of Integrin-RGD Binding in Live Cells from Automated Micropipette and Label-Free Optical Data.

Authors:  Tamás Gerecsei; Péter Chrenkó; Nicolett Kanyo; Beatrix Péter; Attila Bonyár; Inna Székács; Balint Szabo; Robert Horvath
Journal:  Biosensors (Basel)       Date:  2021-01-24

Review 4.  Tumor Targeting via Integrin Ligands.

Authors:  Udaya Kiran Marelli; Florian Rechenmacher; Tariq Rashad Ali Sobahi; Carlos Mas-Moruno; Horst Kessler
Journal:  Front Oncol       Date:  2013-08-30       Impact factor: 6.244

Review 5.  Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.

Authors:  Angelo Corti; Flavio Curnis; Gilda Rossoni; Fabrizio Marcucci; Vanesa Gregorc
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

6.  A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.

Authors:  Tobias G Kapp; Florian Rechenmacher; Stefanie Neubauer; Oleg V Maltsev; Elisabetta A Cavalcanti-Adam; Revital Zarka; Ute Reuning; Johannes Notni; Hans-Jürgen Wester; Carlos Mas-Moruno; Joachim Spatz; Benjamin Geiger; Horst Kessler
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

7.  Size-Dependent Cellular Uptake of RGD Peptides.

Authors:  Isabell Kemker; Rebecca C Feiner; Kristian M Müller; Norbert Sewald
Journal:  Chembiochem       Date:  2019-10-25       Impact factor: 3.164

Review 8.  It's Time to Shift the Paradigm: Translation and Clinical Application of Non-αvβ3 Integrin Targeting Radiopharmaceuticals.

Authors:  Susanne Kossatz; Ambros Johannes Beer; Johannes Notni
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

9.  Glycine N-methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing.

Authors:  Angelo Corti; Anna Maria Gasparri; Michela Ghitti; Angelina Sacchi; Francesco Sudati; Martina Fiocchi; Valentina Buttiglione; Laura Perani; Alessandro Gori; Silvia Valtorta; Rosa Maria Moresco; Fabio Pastorino; Mirco Ponzoni; Giovanna Musco; Flavio Curnis
Journal:  Adv Funct Mater       Date:  2017-09-26       Impact factor: 18.808

10.  NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors.

Authors:  Flavio Curnis; Martina Fiocchi; Angelina Sacchi; Alessandro Gori; Anna Gasparri; Angelo Corti
Journal:  Nano Res       Date:  2016-03-04       Impact factor: 8.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.